Smartphone Cough Recordings to Help Screen for Tuberculosis
Tests whether a phone app can sort cough sounds to flag possible tuberculosis.
Key facts
- Who runs it
- University of Stellenbosch
- Where
- Cape Town, South AfricaSee the siteAlso in 1 other country, 1 site
- Trial code
- Registry title
- Cough Audio Classification as a TB Triage Test
- Status
- Recruiting
- People taking part
- 1,751 people, planned
- Started
- 19 Apr 2022
- Expected to end
- 30 Dec 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Cough sounds
- Record updated
- 6 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 12 or older who have had a cough for at least two weeks. It tests a smartphone app that listens to coughs to help find tuberculosis (TB).
- Age
- 12 years or older
- Sex
- All sexes can join.
- Disease stage
- A prolonged cough lasting at least two weeks.
- Earlier treatment
- No treatment for TB in the 60 days before joining.
- Biomarker or test result
- Known HIV status, or willing to have standard HIV testing and counseling.
Main reasons for not taking part
- Refuses informed consent
- Treated for TB in the 60 days before joining
- Cannot give a sputum sample for lab testing
- Coughs up blood or has a bloody cough with any forced cough for the audio recordings
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- participant must be at least 12 years old
- participant must have a prolonged cough (for at least two weeks)
- participant must provide informed consent
- participant shall have a known HIV status or be willing to undergo standard of care HIV testing and counseling
Who cannot take part
- individuals who have received treatment for TB in the 60 days prior to enrolment
- individuals who refuse informed consent
- individuals who are unable to provide a sputum specimen for microbiological testing
- individuals who have haemoptysis or a bloody cough with any forced coughs for audio recordings
This trial is currently available in South Africa.
Also in 1 other country, 1 site
- Stellenbosch UniversityCape Town, South AfricaContact: Grant Theron, PhDTaking people
About the trial
What the trial wants to find out
TB is the single biggest infectious cause of death (1.5 million died in 2018), killing more HIV-positive people than any other disease, and is arguably the most important poverty-related disease in the world. TB's estimated incidence in Africa has been declining over recent years but progress is slow and plateauing. To avert stagnation, truly innovative and ambitious technologies are needed, especially those that improve case finding and time-to-diagnosis as, in mathematical models based on the TB care cascade framework, interventions that accomplish this will have the most impact on disrupting population-level transmission, including when deployed at facilities where patients are readily accessible. Critically, these interventions (triage tests) must promote access to confirmatory testing (e.g., Xpert MTB/RIF Ultra) by enabling patients to be referred rapidly and efficiently during the same visit. The investigators will optimise and evaluate a technology that, aside from the investigators early case-controlled study to show feasibility, is hitherto not meaningfully investigated for TB. This gap is alarming given, on one hand, the enormity of the TB epidemic and the need for a triage test and, on the other hand, promising proofs-of-concept that demonstrate high diagnostic accuracy of cough audio classifier for respiratory diseases such as pneumonia, asthma. pertussis, croup, and COPD. In some cases, these classification systems are CE-marked, awaiting FDA-approval, and subject to late-stage clinical trials. This demonstrates the promise of the underlying technological principle. CAGE-TB's innovation is further enhanced by: applying advanced machine learning methods that the team have specifically developed for TB patient cough audio analysis, use of mixed methods research - drawing from health economics, implementation science, and medical anthropology - to inform product design and assess barriers and facilitators to implementation, and uniquely for a TB diagnostic test, its potential deployment as a pure mHealth (smartphone-based) innovation that mitigates many barriers that typically jeopardise TPP criteria fulfilment.
The 2 groups in the trial
- Discovery Cohort
An anticipated number of 473 participants will be recruited in Cape Town, South Africa. Data (cough audio) will be collected and used to train a machine learning algorithm. The cough audio signal specific for TB will be refined. During the discovery phase, the ground truth obtained through biological testing of sputum specimens will be used to inform the machine learning.
Treatment: Cough sounds
- Validation Cohort
In the validation phase, the cough audio signature will have its sensitivity and specificity measured in new patients in Cape Town, South Africa (n=511) and Kampala, Uganda (n=767). The data will be used to evaluate the performance of the algorithm.
Treatment: Cough sounds
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Automated Smartphone-based Cough Audio Classification for Rapid Tuberculosis Triage Testing (Cough Audio triaGE for TB; CAGE-TB)
- Plain-language title
- Smartphone Cough Recordings to Help Screen for TuberculosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 6 May 2026